Research & Development
Boehringer Ingelheim announces availability of new Quarterable Snap-Tab design for PREVICOX (firocoxib) Chewable Tablets
8 October 2026 - Pharmaceutical company Boehringer Ingelheim announced on Wednesday the availability of the new Quarterable Snap-Tab design for PREVICOX (firocoxib) Chewable Tablets for dogs, followin...
Okami Medical receives FDA approval for expanded indication of LOBO Vascular Occluder
8 October 2026 - Medical technology company Okami Medical announced on Wednesday that it has received approval from the US FDA for an expanded indication of its LOBO Vascular Occlusion System.The expa...
Kedrion to be honoured at Premier's Supplier Innovation Celebration
7 October 2026 - Plasma-derived therapies company Kedrion Biopharma announced on Tuesday that it will be honoured by Premier Inc, a technology-driven healthcare improvement company, during the annual ...
Enliven Therapeutics reaches FDA alignment on relcobatinib (ELVN-001) Phase 3 trial design for previously treated CML
7 October 2026 - Enliven Therapeutics Inc (Nasdaq:ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, announced on Tuesday that i...
Zydus and MSN announce US launch of generic Adempas (Riociguat Tablets)
6 October 2026 - India-based pharmaceutical companies Zydus Lifesciences Limited and MSN Laboratories Private Limited announced on Monday the launch of Riociguat Tablets, 0.5 mg, 1 mg, 1.5 mg, 2 mg an...
FDA approves second Reykjavik manufacturing suite for AVT02
5 October 2026 - Global biotechnology company Alvotech (NASDAQ: ALVO; STO: ALVO-SDB), which develops and manufactures biosimilar medicines, said on Monday it has received US Food and Drug Administrati...